Finding 481104 (2022-008)

Significant Deficiency
Requirement
H
Questioned Costs
-
Year
2022
Accepted
2024-08-14
Audit: 317239
Organization: National Casa Association (WA)
Auditor: Bdo USA PC

AI Summary

  • Core Issue: National CASA/GAL charged costs to federal grants that were incurred after the funding period, violating grant requirements.
  • Impacted Requirements: Costs must be allowable and incurred within the specified funding period; proper documentation and approval of cost allocations are necessary.
  • Recommended Follow-Up: Ensure only costs incurred during the funding period are charged, and implement a robust documentation and review process for all cost allocations.

Finding Text

Federal Agency: Department of Justice Federal Assistance Listing Numbers: 16.756, 16.726 Programs: Court Appointed Special Advocates, Juvenile Mentoring Program Award/Pass-Through Entity Identifying Numbers: 2018-CH-BX-K001, 15PJDP-21-GK-02762-CASA, 2019-MU-FX-0004, 2020-JU-FX-0028 Criteria: Where a funding period is specified, a recipient may charge to the grant only allowable costs resulting from obligations incurred during the funding period and any pre-award costs authorized by the federal awarding agency. Unless the federal awarding agency authorizes an extension, a recipient shall liquidate all obligations incurred under the award no later than 90 calendar days after the funding period or the date of completion as specified in the terms and conditions of the award or in agency implementing instructions. Condition: National CASA/GAL allocated expenditures to the grant during and after the funding period. During our testing of costs, we noted the below: For Court Appointed Special Advocates: • Three of 136 transactions were either fully or partially incurred after the grant period. • 22 of 136 transactions lacked documentation of review and approval of the allocation of costs made through journal entries. For Juvenile Mentoring Program: • 27 of 97 transactions lacked documentation of review and approval of the allocation of costs made through journal entries. Cause: National CASA/GAL did not have procedures in place to document, and maintain the documentation of, the review and approval of the allocation methodology and the allocation of costs through the journal entry process. Effect or Potential Effect: Without consistent application of the controls in place to ensure costs are allowable and reimbursable, and properly recognized based on the date of incurrence, National CASA/GAL could incorrectly charge expenditures to the federal programs. Questioned Costs Court Appointed Special Advocates: Below reporting threshold. Questioned Costs Juvenile Mentoring Program: None. Context: This is a condition identified per review of National CASA/GAL’s compliance with specified requirements not using a statistically valid sample. For the Court Appointed Special Advocates Program, 16 transactions totaling to $85,362 in costs incurred at the end of the period of performance were tested from a population of 43 transactions totaling to $150,874. Three transactions with costs incurred outside the period of performance were identified totaling $4,917. Additionally, 120 transactions (60 payroll and 60 non-payroll) were tested from populations of expenditures incurred throughout 2022. Of these, 22 non-payroll transactions, totaling to $15,405, were identified, which lacked documentation of review and approval of the allocation of costs made through journal entries. One non-payroll transaction of $95 was identified lacking relevant supporting documentation. Identification as a Repeat Finding: Not a repeat finding. Recommendation: We recommend that only costs incurred during the appropriate funding period be charged, and that this be appropriately documented and reviewed. Views of Responsible Officials: Management concurs with the finding that costs were incurred outside the appropriate funding period. Management will produce and maintain documentation supporting the review and approval of the funding period associated with costs incurred and their proper inclusion in the applicable period. Management will update policies and procedures to periodically review subrecipient details to ensure compliance with funding periods.

Categories

Period of Performance Subrecipient Monitoring Allowable Costs / Cost Principles

Other Findings in this Audit

  • 481081 2022-002
    Significant Deficiency
  • 481082 2022-002
    Significant Deficiency
  • 481083 2022-002
    Significant Deficiency
  • 481084 2022-002
    Significant Deficiency
  • 481085 2022-003
    Material Weakness
  • 481086 2022-003
    Material Weakness
  • 481087 2022-003
    Material Weakness
  • 481088 2022-003
    Material Weakness
  • 481089 2022-004
    Material Weakness
  • 481090 2022-004
    Material Weakness
  • 481091 2022-004
    Material Weakness
  • 481092 2022-004
    Material Weakness
  • 481093 2022-005
    Significant Deficiency
  • 481094 2022-005
    Significant Deficiency
  • 481095 2022-005
    Significant Deficiency
  • 481096 2022-005
    Significant Deficiency
  • 481097 2022-006
    Significant Deficiency
  • 481098 2022-006
    Significant Deficiency
  • 481099 2022-007
    Significant Deficiency
  • 481100 2022-007
    Significant Deficiency
  • 481101 2022-007
    Significant Deficiency
  • 481102 2022-007
    Significant Deficiency
  • 481103 2022-008
    Significant Deficiency
  • 481105 2022-008
    Significant Deficiency
  • 481106 2022-008
    Significant Deficiency
  • 481107 2022-009
    Significant Deficiency
  • 481108 2022-009
    Significant Deficiency
  • 481109 2022-009
    Significant Deficiency
  • 481110 2022-009
    Significant Deficiency
  • 1057523 2022-002
    Significant Deficiency
  • 1057524 2022-002
    Significant Deficiency
  • 1057525 2022-002
    Significant Deficiency
  • 1057526 2022-002
    Significant Deficiency
  • 1057527 2022-003
    Material Weakness
  • 1057528 2022-003
    Material Weakness
  • 1057529 2022-003
    Material Weakness
  • 1057530 2022-003
    Material Weakness
  • 1057531 2022-004
    Material Weakness
  • 1057532 2022-004
    Material Weakness
  • 1057533 2022-004
    Material Weakness
  • 1057534 2022-004
    Material Weakness
  • 1057535 2022-005
    Significant Deficiency
  • 1057536 2022-005
    Significant Deficiency
  • 1057537 2022-005
    Significant Deficiency
  • 1057538 2022-005
    Significant Deficiency
  • 1057539 2022-006
    Significant Deficiency
  • 1057540 2022-006
    Significant Deficiency
  • 1057541 2022-007
    Significant Deficiency
  • 1057542 2022-007
    Significant Deficiency
  • 1057543 2022-007
    Significant Deficiency
  • 1057544 2022-007
    Significant Deficiency
  • 1057545 2022-008
    Significant Deficiency
  • 1057546 2022-008
    Significant Deficiency
  • 1057547 2022-008
    Significant Deficiency
  • 1057548 2022-008
    Significant Deficiency
  • 1057549 2022-009
    Significant Deficiency
  • 1057550 2022-009
    Significant Deficiency
  • 1057551 2022-009
    Significant Deficiency
  • 1057552 2022-009
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
16.756 Court Appointed Special Advocates $7.69M
16.726 Juvenile Mentoring Program $1.47M